|
COMMERCE BUSINESS DAILY ISSUE OF DECEMBER 10,1997 PSA#1989National Cancer Institute, Research Contracts Branch, PCCS, Executive
Plaza South, Room 635, Bethesda, Md 20892 A -- A PHASE I NON-RANDOMIZED MULTIPLE-DOSE SAFETY, PHARMACOLINETIC
AND PHARMACODYNAMIC (BIOMARKER MODULATION) STUDY OF AN ANTIESTROGEN IN
WOMEN WITH NEWLY DIAGNOSED BREASE CANCER POC Schyuler T. Eldridge,
Contract Specialist, 301-435-3794; Theresa H. Shroff, Contracting
Officer, 301-435-3796. CNT N01-CN-85035 AMT $2,782,847 DTD 120497 TO
University of Kansa Medical Center, 3901 Rainbow Blvd., Kansas City, KS
66160 E-MAIL: Schuyler T. Eldridge, eldridges@rcb.nci.nih.gov. (0342) Loren Data Corp. http://www.ld.com (SYN# 0312 19971210\A-0004.AWD)
A - Research and Development Index Page
|
|